Literature DB >> 29686040

Innate Immunity to Enteric Hepatitis Viruses.

Zongdi Feng1, Stanley M Lemon2.   

Abstract

Although hepatitis A virus (HAV) and hepatitis E virus (HEV) are both positive-strand RNA viruses that replicate in the cytoplasm of hepatocytes, there are important differences in the ways they induce and counteract host innate immune responses. HAV is remarkably stealthy because of its ability to evade and disrupt innate signaling pathways that lead to interferon production. In contrast, HEV does not block interferon production. Instead, it persists in the presence of an interferon response. These differences may provide insight into HEV persistence in immunocompromised patients, an emerging health problem in developed countries.
Copyright © 2019 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29686040      PMCID: PMC6396338          DOI: 10.1101/cshperspect.a033464

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  101 in total

1.  Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43.

Authors:  Magdalena Sarasin-Filipowicz; Xueya Wang; Ming Yan; Francois H T Duong; Valeria Poli; Douglas J Hilton; Dong-Er Zhang; Markus H Heim
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

Review 2.  Intestinal epithelial cells: regulators of barrier function and immune homeostasis.

Authors:  Lance W Peterson; David Artis
Journal:  Nat Rev Immunol       Date:  2014-03       Impact factor: 53.106

3.  STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease.

Authors:  Jan Petrasek; Arvin Iracheta-Vellve; Timea Csak; Abhishek Satishchandran; Karen Kodys; Evelyn A Kurt-Jones; Katherine A Fitzgerald; Gyongyi Szabo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-19       Impact factor: 11.205

4.  Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease.

Authors:  Yogesh A Karpe; Kavita S Lole
Journal:  J Gen Virol       Date:  2011-06-08       Impact factor: 3.891

Review 5.  Inflammasomes: mechanism of action, role in disease, and therapeutics.

Authors:  Haitao Guo; Justin B Callaway; Jenny P-Y Ting
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

Review 6.  Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses.

Authors:  Lin Qu; Stanley M Lemon
Journal:  Semin Liver Dis       Date:  2010-10-19       Impact factor: 6.115

7.  Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.

Authors:  Ibrahim M Sayed; Lieven Verhoye; Laurence Cocquerel; Florence Abravanel; Lander Foquet; Claire Montpellier; Yannick Debing; Ali Farhoudi; Czeslaw Wychowski; Jean Dubuisson; Geert Leroux-Roels; Johan Neyts; Jacques Izopet; Thomas Michiels; Philip Meuleman
Journal:  Gut       Date:  2016-03-22       Impact factor: 23.059

8.  The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells.

Authors:  Milan Surjit; Bhavna Varshney; Sunil K Lal
Journal:  BMC Biochem       Date:  2012-05-16       Impact factor: 4.059

Review 9.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

10.  Analysis of antiviral response in human epithelial cells infected with hepatitis E virus.

Authors:  Pradip B Devhare; Subhashis N Chatterjee; Vidya A Arankalle; Kavita S Lole
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

View more
  10 in total

1.  CD8+ lymphocytes but not B lymphocytes are required for protection against chronic hepatitis E virus infection in chickens.

Authors:  Eda Rogers; Stephanie Michelle Todd; Frank William Pierson; Scott P Kenney; Connie Lynn Heffron; Danielle M Yugo; Shannon R Matzinger; Elena Mircoff; Irene Ngo; Charles Kirby; Michaela Jones; Paul Siegel; Peter Jobst; Karen Hall; Robert J Etches; Xiang-Jin Meng; Tanya LeRoith
Journal:  J Med Virol       Date:  2019-07-25       Impact factor: 2.327

Review 2.  Hepatitis A Virus Genome Organization and Replication Strategy.

Authors:  Kevin L McKnight; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2018-12-03       Impact factor: 6.915

Review 3.  Hepatitis A Virus and Hepatitis E Virus: Emerging and Re-Emerging Enterically Transmitted Hepatitis Viruses.

Authors:  Stanley M Lemon; Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-06-03       Impact factor: 6.915

Review 4.  Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis E Virus Genotype 1 and 2 Infections.

Authors:  Rakesh Aggarwal; Amit Goel
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

Review 5.  Nonhuman Primate Models of Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Robert E Lanford; Christopher M Walker; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

Review 6.  Murine Models of Hepatitis A Virus Infection.

Authors:  Asuka Hirai-Yuki; Jason K Whitmire; Michael Joyce; D Lorne Tyrrell; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

7.  IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation.

Authors:  Sonam Popli; Sukanya Chakravarty; Shumin Fan; Anna Glanz; Siddhesh Aras; Laura E Nagy; Ganes C Sen; Ritu Chakravarti; Saurabh Chattopadhyay
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-06       Impact factor: 12.779

8.  Additive Effects of Zinc Chloride on the Suppression of Hepatitis A Virus Replication by Interferon in Human Hepatoma Huh7 Cells.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Hiroshi Takahashi; Mariko Fujisawa; Naoki Matsumoto; Hiroaki Okamoto; Mitsuhiko Moriyama
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 9.  Induction and Suppression of Innate Antiviral Responses by Hepatitis A Virus.

Authors:  Xin Cao; Yu-Jia Xue; Jiang-Long Du; Qiang Xu; Xue-Cai Yang; Yan Zeng; Bo-Bo Wang; Hai-Zhen Wang; Jing Liu; Kui-Zheng Cai; Zhong-Ren Ma
Journal:  Front Microbiol       Date:  2018-08-17       Impact factor: 5.640

Review 10.  Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Hiroshi Takahashi; Taku Mizutani; Naoki Matsumoto; Kazushige Nirei; Mitsuhiko Moriyama
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.